insulin 338
Recombinant proteinexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 21, 2013 (NCT01796366)
Timeline
Indications
Mechanism of action
- Insulin-like growth factor I receptorSupplementation
IGF1R supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- insulin 338
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02470039 | Phase 2 | Jun 1, 2015 | Novo Nordisk |
| NCT02304627 | Phase 1 | Nov 1, 2014 | Novo Nordisk |
| NCT02220296 | Phase 1 | Aug 1, 2014 | Novo Nordisk |
| NCT01931137 | Phase 1 | Aug 1, 2013 | Novo Nordisk |
| NCT01796366 | Phase 1 | Feb 21, 2013 | Novo Nordisk |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novo Nordisk | For profit | 5 | 5 | 2 | 2013 |
1 organizations
Page 1 / 1